Company intelligence / Profile preview

Ventrica

Fremont, California, United Statesventrica.co.uk ↗

Ownership: Private
Development stage: Commercial

Overview

Ventrica developed a new generation of heart bypass devices designed to revascularize coronary arteries by shunting blood directly from the left ventricle, potentially changing conventional coronary artery bypass graft surgery. The company was acquired after raising $25.5M in funding. Clinical results are not publicly detailed.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

MedtronicInterWest PartnersAtherton Venture Partners

Beyond the preview

Go deeper on Ventrica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventrica.

Explore the full profile